Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.800
-0.170 (-4.28%)
At close: May 11, 2026, 4:00 PM EDT
3.700
-0.100 (-2.63%)
After-hours: May 11, 2026, 6:27 PM EDT

Whitehawk Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-115.81-20.6-63.69-65.77-60.51-110.09
Depreciation & Amortization
0.020.080.190.170.160.11
Stock-Based Compensation
10.399.8710.8411.959.642.11
Other Adjustments
-45.44-88.72-0.84-2.622.8973.21
Change in Receivables
--1-0.42-3.63-1.8614.15
Changes in Inventories
-0.171.12-3.27-1.86-
Changes in Accounts Payable
-0.553.92-9.77-0.133.228.29
Changes in Other Operating Activities
-0.12-1.163.023.62-1.32-10.19
Operating Cash Flow
-107.78-97.43-59.55-59.66-49.64-22.42
Capital Expenditures
-0-0.55-1.65-3.97-0.44-0.05
Purchases of Investments
-167.87-148.69-36.48-64.44-145.19-
Proceeds from Sale of Investments
83.7759.8563.34151.6212.75-
Proceeds from Business Divestments
-0.07101.29----
Other Investing Activities
-----25.2
Investing Cash Flow
-84.1811.8925.283.21-132.8925.15
Issuance of Common Stock
0.04100.080.150.4973.28155.83
Net Common Stock Issued (Repurchased)
0.04100.080.150.4973.28155.83
Common Dividends Paid
------4.41
Other Financing Activities
-0.84-5.7-0.02-0.16-0.66-9.62
Financing Cash Flow
-0.8394.380.130.3372.62141.8
Net Cash Flow
-192.788.83-34.2223.87-109.91144.53
Free Cash Flow
-107.78-97.99-61.2-63.64-50.08-22.47
FCF Margin
--1371.38%-235.55%-261.29%-329.15%-2006.16%
Free Cash Flow Per Share
-1.56-1.58-2.26-2.36-2.22-2.52
Levered Free Cash Flow
-116.45-18.14-70.79-69.35-60.76-112.58
Unlevered Free Cash Flow
-123.35-111.94-74.55-75.51-62.92-113.06
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q